These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2162062)

  • 21. The evidence justifying immunosuppression therapy in multiple sclerosis.
    Mertin J
    Proc R Soc Med; 1977 Dec; 70(12):871-4. PubMed ID: 202967
    [No Abstract]   [Full Text] [Related]  

  • 22. Early treatment of multiple sclerosis with Rebif (recombinant human interferon beta): design of the study.
    Comi G; Barkhof F; Durelli L; Edan G; Fernandez O; Filippi M; Hartung HP; Hommes OR; Seeldrayers P; Soelberg-Sorensen P
    Mult Scler; 1995; 1 Suppl 1():S24-7. PubMed ID: 9345394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acute relapses in multiple sclerosis. Emergency diagnosis and therapy].
    Hielscher H
    Med Welt; 1981 Feb; 32(6):185-8. PubMed ID: 6258006
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapeutic trials in multiple sclerosis.
    Noseworthy JH; Seland TP; Ebers GC
    Can J Neurol Sci; 1984 Aug; 11(3):355-62. PubMed ID: 6205737
    [No Abstract]   [Full Text] [Related]  

  • 25. Cyclosporine and multiple sclerosis: the cons.
    Rudge P
    Neurology; 1988 Jul; 38(7 Suppl 2):29-30. PubMed ID: 3290712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Is immunosuppression a future therapeutic strategy for multiple sclerosis?].
    Edan G; Coustans M
    Pathol Biol (Paris); 2000 Mar; 48(2):114-20. PubMed ID: 10815287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of multiple sclerosis.
    Poser CM
    Compr Ther; 1981 Apr; 7(4):53-9. PubMed ID: 6263543
    [No Abstract]   [Full Text] [Related]  

  • 28. [Lymphocyto-plasmapheresis for relapsing multiple sclerosis].
    Jyoichi T; Kamegai M; Noda Y; Shimojo S; Miyahara T
    Rinsho Shinkeigaku; 1986 Sep; 26(9):907-9. PubMed ID: 3791770
    [No Abstract]   [Full Text] [Related]  

  • 29. A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLIN.
    Patti F; Amato MP; Filippi M; Gallo P; Trojano M; Comi GC
    J Neurol Sci; 2004 Aug; 223(1):69-71. PubMed ID: 15261564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppression and plasmapheresis in chronic progressive multiple sclerosis. Design of a clinical trial.
    Hauser SL; Dawson DM; Lehrich JR; Beal MF; Kevy SV; Weiner HL
    Arch Neurol; 1983 Oct; 40(11):687-90. PubMed ID: 6354151
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical experience with azathioprine: the pros.
    Ellison GW; Myers LW; Mickey MR; Graves MC; Tourtellotte WW; Nuwer MR
    Neurology; 1988 Jul; 38(7 Suppl 2):20-3. PubMed ID: 3290709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The problem and value of therapy in multiple sclerosis].
    Hitzschke B; Meyer-Rienecker HJ; Buddenhagen F; Richter M
    Psychiatr Neurol Med Psychol (Leipz); 1988 Oct; 40(10):598-608. PubMed ID: 3237866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A closer look at plasmapheresis in multiple sclerosis: the cons.
    Tindall R
    Neurology; 1988 Jul; 38(7 Suppl 2):53-6. PubMed ID: 3290716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of multiple sclerosis].
    Wührich R
    Schweiz Rundsch Med Prax; 1976 Apr; 65(17):495-8. PubMed ID: 185607
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative clinical trial of cyclosporine in multiple sclerosis: the pros.
    Dommasch D
    Neurology; 1988 Jul; 38(7 Suppl 2):28-9. PubMed ID: 3290711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatments of multiple sclerosis].
    Roullet R
    Rev Prat; 1991 Sep; 41(20):1919-23. PubMed ID: 1656516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Extracorporeal therapy of rheumatoid arthritis].
    Aseeva EA; Solov'ev SK; Chiklikchi AS
    Ter Arkh; 2001; 73(6):70-5. PubMed ID: 11521529
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of plasmapheresis in therapy of systemic lupus erythematosus: a controlled study].
    Zielinski C; Müller C; Smolen J
    Acta Med Austriaca; 1988; 15(5):155-8. PubMed ID: 3064527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy of multiple sclerosis].
    Kesselring J
    Schweiz Med Wochenschr; 1984 Sep; 114(35):1186-90. PubMed ID: 6091263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advances in the treatment of multiple sclerosis?].
    Tackenberg B; Himmerich H; Wellek A; Oertel WH; Sommer N
    MMW Fortschr Med; 2007 May; 149 Suppl 2():51-5. PubMed ID: 17724968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.